Kyle Staller, MD MPH
Director, Gastrointestinal Motility Laboratory
Massachusetts General Hospital
Harvard Medical School
Boston, MA, United States
All disclosed relationships have been reviewed and managed prior to the start of this activity. Any relevant relationships will be listed below. ardelyx: Consultant (Ongoing), Grant/Research Support (Ongoing); ferring pharma: Consultant (Terminated, July 17, 2025); gemelli: Consultant (Terminated, October 7, 2024); laborie: Consultant (Terminated, August 9, 2024); salix: Consultant (Terminated, May 16, 2024); Takeda: Consultant (Ongoing)